Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
Doxorubicin is one of the most common antitumor drugs. However, cardiotoxicity’s side effect limits its clinical applicability. In the present study, Gene Expression Omnibus (GEO) datasets were applied to reanalyze differentially expressed genes (DEGs) and construct weighted correlation network anal...
Main Authors: | Rui Zhang, Chunshu Hao, Zhenjun Ji, Yangyang Qu, Wenjie Zuo, Mingming Yang, Pengfei Zuo, Abdlay Carvalho, Genshan Ma, Yongjun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/8347759 |
Similar Items
-
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
by: Mohd Amaan, et al.
Published: (2024-12-01) -
Prognostic value of a disintegrin and metalloproteinase Domain-8 in heart failure
by: Zhenjun Ji, et al.
Published: (2024-06-01) -
Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
by: Rui Fan, et al.
Published: (2023-08-01) -
Doxorubicin-induced cardiotoxicity – Are plants the answer?
by: Pedro Mendes-Ferreira, et al.
Published: (2025-03-01) -
Doxorubicin-induced cardiotoxicity and risk factors
by: Carl Belger, et al.
Published: (2024-02-01)